G. García-Manero

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL)

Stefan Faderl, MJ Keating, K-A Do et al. · Leukemia · 2002 · 119 citations

Life Sciences, Molecular Biology, Oncology +16

Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies

Gautam Borthakur, Michael G. Rosenblum, Moshe Talpaz et al. · Haematologica · 2012 · 73 citations · Full text

Medicine, Hematology, Pharmacology +17

Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome

Ravindra Kumar Garg, S. Faderl, G. García-Manero et al. · Leukemia · 2009 · 46 citations

Medicine, Hematology, Immunology +17

Efficacy of nilotinib (AMN107) in patients (Pts) with newly diagnosed, previously untreated philadelphia chromosome (Ph)- positive chronic myelogenous leukemia in early chronic phase (CML-CP)

Jörge E. Cortes, Susan O’Brien, A. Ferrajoli et al. · Journal of Clinical Oncology · 2008 · 34 citations

Medicine, Pharmacology, Pharmacotherapy +13

Combined Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR), an Active Frontline Regimen for High-Risk Patients with CLL.

William G. Wierda, Susan O’Brien, Alessandra Ferrajoli et al. · Blood · 2007 · 27 citations

Medicine, Oncology, Pharmacotherapy +10